Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Proteostasis Therapeutics, Inc.

NASDAQ: PTITechnology / Application Software / India
3.99-0.0400-0.99%Vol 678 4921Y Perf 28.63%
Feb 21st, 2019 16:00
BID3.98 ASK3.99
Open4.03 Previous Close4.03
Pre-Market- After-Trading4.02
 - -%  0.03 0.75%
Target Price
14.00 
Analyst Rating
Strong Buy 1.25
Potencial %
250.88 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-71/-71 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/31/31 
Growth Ranking
★+     39.11
Insiders Shares Cnt. % 3/6/12M
-100/-8/-8 
Income Ranking
 —    -
Market Cap (mil)146 
Earnings Rating
Sell
Price Range Ratio 52wk %
26.30 
Earnings Date
13th Mar 2019

Today's Price Range

3.874.09

 

52wk Range

1.7110.38

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
37.11%
3 Months
-28.62%
6 Months
63.52%
1 Year
28.63%
3 Years
-37.46%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
PTI3.99-0.0400-0.99
AAPL171.06-0.9700-0.56
GOOG1 096.97-16.8300-1.51
MSFT109.412.26002.11
XOM77.82-0.7100-0.90
WFC49.56-0.2500-0.50
JNJ135.42-0.9300-0.68
FB160.04-2.5200-1.55
GE10.03-0.0700-0.69
JPM105.47-0.2200-0.21
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
4.00
Current Ratio
4.20
Long Term Debt to Total Capital
0.26
Total Debt to Equity
0.37
Interest Coverage
-
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-1 326.60
EBITDA Margin
-1 311.80
Pre-tax Profit Margin
-711.30
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
4.90
PS Ratios
74.07
Price to Cash Flow
-
Price to Free Cash Flow
-4.80
Cash Flow Per Share
-1.54
Price to Tangible Book
4.90
Book Value per Share
0.77
Enterprise Value (in ths.)
158 630
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
141.11
ROE last 12 Months
-151.90
Return on Assets (5Y Avg)
-51.37
ROA last 12 Months
-94.08
Return on Capital (5Y Avg)
-
ROC last 12 Months
-111.10
Return on invested Capital Q
-29.88
Return on invested Capital Y
-80.00
Assets Turnover
0.00
Receivables Turnover
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
2 840
Revenue per Share
0.06
Revenue Growth 3 Years
-9.18
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.46-0.50-8.70
Q02 2018-0.41-0.43-4.88
Q01 2018-0.51-0.3237.25
Q04 2017-0.65-0.5121.54
Q03 2017-0.63-0.5611.11
Q02 2017-0.61-0.68-11.48
Q01 2017-0.58-0.60-3.45
Q04 2016-0.51-0.3825.49
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.460.00-
12/2018 FY-1.688.70Positive
3/2019 QR-0.500.00-
12/2019 FY-2.100.00-
Next Report Date13th Mar 2019
Estimated EPS Next Report-0.46
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume678 492
Shares Outstanding (in ths.)36 697
Trades Count2 831
Dollar Volume2 475 565
Avg. Volume1 109 233
Avg. Weekly Volume958 430
Avg. Monthly Volume1 386 383
Avg. Quarterly Volume1 073 479

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

66%34%

Bearish Bullish

65%35%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
3 (75.00 %)
3 (75.00 %)
Moderate Buy
1 (25.00 %)
1 (25.00 %)
1 (25.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.25
Strong Buy
1.25
Strong Buy
1.25

There are no comments yet.

News